Status:
COMPLETED
Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria
Lead Sponsor:
The Mentor Initiative
Collaborating Sponsors:
University of Nevada, Las Vegas
Hacettepe University
Conditions:
Leishmaniasis, Cutaneous
Vector Borne Diseases
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
The aim of this study is to determine the efficacy of Mosquito Shield (spatial repellent) in reducing cutaneous leishmaniasis case incidence among internally displaced persons and sandfly density in t...
Eligibility Criteria
Inclusion
- Known history of cutaneous leishmaniasis in camp Sleeping under same shelter type (all UNHCR tents / plastic sheets) Camp easily accessible by road Camps a minimum of 5km apart Adequate security levels
Exclusion
- Camps closer than 5km from a camp included in the study Camps with no previously recorded cases of cutaneous leishmaniasis Displaced communities living outside of defined camp settings
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
18404 Patients enrolled
Trial Details
Trial ID
NCT06917040
Start Date
February 1 2021
End Date
April 1 2022
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The MENTOR Initiative, North East Syria
Ar-Raqqa, Syria